JP2020532531A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020532531A5 JP2020532531A5 JP2020512411A JP2020512411A JP2020532531A5 JP 2020532531 A5 JP2020532531 A5 JP 2020532531A5 JP 2020512411 A JP2020512411 A JP 2020512411A JP 2020512411 A JP2020512411 A JP 2020512411A JP 2020532531 A5 JP2020532531 A5 JP 2020532531A5
- Authority
- JP
- Japan
- Prior art keywords
- nitric oxide
- ino
- oxide according
- administered
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 claims 34
- 208000002815 pulmonary hypertension Diseases 0.000 claims 4
- 230000005021 gait Effects 0.000 claims 2
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 1
- 201000009794 Idiopathic Pulmonary Fibrosis Diseases 0.000 claims 1
- 208000029523 Interstitial Lung disease Diseases 0.000 claims 1
- 208000019693 Lung disease Diseases 0.000 claims 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 1
- 208000036971 interstitial lung disease 2 Diseases 0.000 claims 1
- 230000007774 longterm Effects 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 239000001301 oxygen Substances 0.000 claims 1
- 238000002640 oxygen therapy Methods 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762552022P | 2017-08-30 | 2017-08-30 | |
| US62/552,022 | 2017-08-30 | ||
| US201762611325P | 2017-12-28 | 2017-12-28 | |
| US62/611,325 | 2017-12-28 | ||
| PCT/US2018/048526 WO2019046415A1 (en) | 2017-08-30 | 2018-08-29 | USE OF INHALED NITRIC OXIDE FOR THE TREATMENT OF PULMONARY HYPERTENSION ASSOCIATED WITH PULMONARY DISEASE |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020532531A JP2020532531A (ja) | 2020-11-12 |
| JP2020532531A5 true JP2020532531A5 (enExample) | 2021-10-07 |
Family
ID=65526008
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020512411A Pending JP2020532531A (ja) | 2017-08-30 | 2018-08-29 | 肺疾患に関連付けられる肺高血圧症の治療のための吸入用一酸化窒素の使用 |
| JP2020512022A Pending JP2020532521A (ja) | 2017-08-30 | 2018-08-29 | 右室及び／又は左室機能の改善のための吸入用一酸化窒素の使用 |
| JP2023080033A Pending JP2023100985A (ja) | 2017-08-30 | 2023-05-15 | 右室及び／又は左室機能の改善のための吸入用一酸化窒素の使用 |
| JP2024209997A Pending JP2025029093A (ja) | 2017-08-30 | 2024-12-03 | 右室及び／又は左室機能の改善のための吸入用一酸化窒素の使用 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020512022A Pending JP2020532521A (ja) | 2017-08-30 | 2018-08-29 | 右室及び／又は左室機能の改善のための吸入用一酸化窒素の使用 |
| JP2023080033A Pending JP2023100985A (ja) | 2017-08-30 | 2023-05-15 | 右室及び／又は左室機能の改善のための吸入用一酸化窒素の使用 |
| JP2024209997A Pending JP2025029093A (ja) | 2017-08-30 | 2024-12-03 | 右室及び／又は左室機能の改善のための吸入用一酸化窒素の使用 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US20200188319A1 (enExample) |
| EP (2) | EP3675719A4 (enExample) |
| JP (4) | JP2020532531A (enExample) |
| KR (1) | KR20200083443A (enExample) |
| CN (3) | CN120131593A (enExample) |
| AU (2) | AU2018323547A1 (enExample) |
| BR (1) | BR112020004205A2 (enExample) |
| CA (4) | CA3073948A1 (enExample) |
| IL (2) | IL272314A (enExample) |
| MX (2) | MX2020002194A (enExample) |
| PH (1) | PH12020500197A1 (enExample) |
| SG (1) | SG11202000893QA (enExample) |
| TW (3) | TWI887195B (enExample) |
| WO (2) | WO2019046415A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102354762B1 (ko) | 2017-02-27 | 2022-01-25 | 써드 폴, 아이엔씨. | 산화 질소 발생 시스템 및 방법 |
| MX2020010523A (es) | 2017-02-27 | 2021-02-09 | Third Pole Inc | Sistemas y metodos para generar oxido nitrico. |
| RU2020113418A (ru) | 2017-02-27 | 2020-10-05 | Cёрд Поул, Инк. | Системы и способы получения оксида азота в амбулаторных условиях |
| US20220096535A1 (en) * | 2019-01-14 | 2022-03-31 | Bellerophon Therapeutics | Combination drug therapies of pde-5 inhibitors and inhaled nitric oxide |
| EP3969416A4 (en) | 2019-05-15 | 2023-11-01 | Third Pole, Inc. | SYSTEMS AND DEVICES FOR GENERATING NITROGEN OXIDE |
| WO2020232414A1 (en) | 2019-05-15 | 2020-11-19 | Third Pole, Inc. | Architectures for production of nitric oxide |
| CN114269685A (zh) | 2019-05-15 | 2022-04-01 | 第三极股份有限公司 | 用于一氧化氮生成的电极 |
| WO2021142472A1 (en) | 2020-01-11 | 2021-07-15 | Third Pole, Inc. | Systems and methods for nitric oxide generation with humidity control |
| US12239460B2 (en) * | 2020-05-06 | 2025-03-04 | Janssen Pharmaceuticals, Inc. | Controlling operation of drug administration devices using surgical hubs |
| MX2022015057A (es) * | 2020-05-29 | 2023-02-09 | Bellerophon Therapeutics | Metodo para administracion pulsatil de un farmaco gaseoso. |
| US20210395905A1 (en) | 2020-06-18 | 2021-12-23 | Third Pole, Inc. | Systems and methods for preventing and treating infections with nitric oxide |
| US12509349B2 (en) | 2020-10-16 | 2025-12-30 | Third Pole, Inc. | Nitric oxide generation process controls |
| WO2023049873A1 (en) | 2021-09-23 | 2023-03-30 | Third Pole, Inc. | Systems and methods for delivering nitric oxide |
| WO2023201363A2 (en) | 2022-04-14 | 2023-10-19 | Third Pole, Inc. | Delivery of medicinal gas in a liquid medium |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI2101777T1 (sl) * | 2006-12-12 | 2015-08-31 | Gilead Sciences, Inc. | Sestavek za zdravljenje pljučne hipertenzije |
| WO2009048521A1 (en) * | 2007-10-11 | 2009-04-16 | Duke University | Potentiating the effect of compound comprising nitric oxide |
| DK2247297T3 (en) * | 2008-01-31 | 2019-03-11 | Univ Vanderbilt | THERAPEUTIC TREATMENT OF LUNG CONDITIONS |
| CA3130908A1 (en) * | 2009-06-30 | 2010-12-30 | Mallinckrodt Hospital Products IP Limited | Methods of treating term and near-term neonates having hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension |
| US20120093948A1 (en) * | 2009-11-20 | 2012-04-19 | Fine David H | Nitric Oxide Treatments |
| CA2819854A1 (en) * | 2010-12-03 | 2012-06-07 | Geno Llc | Nitric oxide treatments |
| AU2013267418B2 (en) * | 2012-05-31 | 2018-06-07 | Mallinckrodt Hospital Products IP Limited | Methods of administering nitric oxide to arterial or arterialized blood |
| US9795756B2 (en) * | 2012-12-04 | 2017-10-24 | Mallinckrodt Hospital Products IP Limited | Cannula for minimizing dilution of dosing during nitric oxide delivery |
| CA2892398C (en) * | 2012-12-04 | 2023-02-14 | Ino Therapeutics Llc | Cannula for minimizing dilution of dosing during nitric oxide delivery |
| WO2015106115A1 (en) * | 2014-01-10 | 2015-07-16 | Ino Therapeutics Llc | Methods of using inhaled nitric oxide gas for treatment of acute respiratory distress syndrome in children |
| WO2015148169A1 (en) * | 2014-03-28 | 2015-10-01 | Shape Medical Systems, Inc. | Pattern recognition system for quantifying the likelihood of the contribution of multiple possible forms of chronic disease to patient reported dyspnea |
| AU2016366697A1 (en) * | 2015-12-11 | 2018-06-28 | Vero Biotech LLC | Method and apparatus for administering gases including nitric oxide |
| EP3397331A4 (en) * | 2015-12-28 | 2019-08-21 | Vero Biotech LLC | METHOD AND APPARATUS FOR ADMINISTERING NITRIC OXIDE WITH ADDITIONAL MEDICAMENTS |
| PL3970730T3 (pl) * | 2016-02-12 | 2024-07-22 | Mallinckrodt Pharmaceuticals Ireland Limited | Układ do stosowania i monitorowania podawanego wziewnie tlenku azotu przy użyciu urządzeń wspomagających pracę lewej komory serca |
-
2018
- 2018-08-29 JP JP2020512411A patent/JP2020532531A/ja active Pending
- 2018-08-29 WO PCT/US2018/048526 patent/WO2019046415A1/en not_active Ceased
- 2018-08-29 KR KR1020207008998A patent/KR20200083443A/ko not_active Ceased
- 2018-08-29 BR BR112020004205-6A patent/BR112020004205A2/pt unknown
- 2018-08-29 CA CA3073948A patent/CA3073948A1/en active Pending
- 2018-08-29 JP JP2020512022A patent/JP2020532521A/ja active Pending
- 2018-08-29 SG SG11202000893QA patent/SG11202000893QA/en unknown
- 2018-08-29 EP EP18852330.2A patent/EP3675719A4/en not_active Withdrawn
- 2018-08-29 MX MX2020002194A patent/MX2020002194A/es unknown
- 2018-08-29 CA CA3266320A patent/CA3266320A1/en active Pending
- 2018-08-29 CN CN202411395162.XA patent/CN120131593A/zh active Pending
- 2018-08-29 CA CA3073949A patent/CA3073949A1/en active Pending
- 2018-08-29 CA CA3266267A patent/CA3266267A1/en active Pending
- 2018-08-29 CN CN201880055684.1A patent/CN111315283A/zh active Pending
- 2018-08-29 AU AU2018323547A patent/AU2018323547A1/en not_active Abandoned
- 2018-08-29 AU AU2018324004A patent/AU2018324004A1/en not_active Abandoned
- 2018-08-29 EP EP18851496.2A patent/EP3675840A4/en not_active Withdrawn
- 2018-08-29 US US16/643,198 patent/US20200188319A1/en not_active Abandoned
- 2018-08-29 US US16/643,167 patent/US20200360647A1/en not_active Abandoned
- 2018-08-29 WO PCT/US2018/048524 patent/WO2019046413A1/en not_active Ceased
- 2018-08-29 CN CN201880055696.4A patent/CN111372577A/zh active Pending
- 2018-08-30 TW TW107130330A patent/TWI887195B/zh active
- 2018-08-30 TW TW107130307A patent/TW201919590A/zh unknown
- 2018-08-30 TW TW112149987A patent/TW202416939A/zh unknown
-
2020
- 2020-01-27 PH PH12020500197A patent/PH12020500197A1/en unknown
- 2020-01-28 IL IL272314A patent/IL272314A/en unknown
- 2020-01-28 IL IL272308A patent/IL272308A/en unknown
- 2020-02-26 MX MX2025004666A patent/MX2025004666A/es unknown
-
2023
- 2023-05-15 JP JP2023080033A patent/JP2023100985A/ja active Pending
-
2024
- 2024-12-03 JP JP2024209997A patent/JP2025029093A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020532531A5 (enExample) | ||
| JP2020033360A5 (enExample) | ||
| JP2020532521A5 (enExample) | ||
| MX2019006938A (es) | Metodos y composiciones para trataminto de hipertension pulmonar y otros trastornos del pulmon. | |
| JP2016516016A5 (enExample) | ||
| RU2017134443A (ru) | Способ лечения с применением традипитанта | |
| JP2016520089A5 (enExample) | ||
| JP2020520963A5 (enExample) | ||
| JP2015522603A5 (enExample) | ||
| JP2019507786A5 (enExample) | ||
| JP2017508737A5 (enExample) | ||
| JP2017061488A5 (enExample) | ||
| JPWO2020033768A5 (enExample) | ||
| CN105412118B (zh) | 治疗急慢性呼吸困难的西药组合物及其制备方法 | |
| JP7369523B2 (ja) | 中等度～重度のインフルエンザの処置 | |
| MX2023002156A (es) | Acido (1r,3s)-3-((5-ciano-4-feniltiazol-2-il)carbamoil)ciclopentan o-1-carboxilico y derivados del mismo para su uso en el tratamiento de enfermedades de las vias respiratorias. | |
| JP2017511307A5 (enExample) | ||
| Bordier | Sleep apnoea in patients with heart failure: part II: therapy | |
| Bednarek | Overlap syndrome of chronic obstructive pulmonary disease and obstructive sleep apnea | |
| JP2018502168A5 (enExample) | ||
| AR128201A1 (es) | USO DE ÓXIDO NÍTRICO INHALADO (iNO) PARA TRATAR PACIENTES CON HIPERTENSIÓN PULMONAR ASOCIADA CON SARCOIDOSIS (PH-SARC) | |
| Pradhan et al. | Efficacy of dexmedetomidine in attenuating hemodynamic and airway responses during extubation: a randomized double-blind study | |
| CA2506956A1 (en) | Synergistic combination comprising roflumilast and (r,r)-formoterol | |
| JP2017524732A5 (enExample) | ||
| AR119669A1 (es) | USO DE ÓXIDO NÍTRICO INHALADO (iNO) PARA MEJORAR LOS NIVELES DE ACTIVIDAD EN PACIENTES CON AFECCIONES PULMONARES |